Gelatin
drugOn this page
Also known as Gelatin limed boneunspecifiedabsorbableabsorbable filmabsorbable powderabsorbable spongeGelatinaGelatineGelofusineGppe infHaemaccelIsoplexVolplex
Summary
Gelatin (CHEMBL2108518) is a phase-3 clinical-stage unknown; indicated across 10 conditions including acute promyelocytic leukemia and acute myocardial infarction.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Indications: 10 conditions
- Clinical trials: 30
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108518 |
| Name | Gelatin |
| Type | Unknown |
| Max phase | 3 |
Also known as: Gelatin, Gelatin limed bone, unspecified, absorbable, absorbable film, absorbable powder, absorbable sponge, Gelatina, Gelatine, Gelofusine, Gppe inf, Haemaccel
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
10 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| acute promyelocytic leukemia | 2 | MONDO:0012883 | EFO:0000224 |
| acute myocardial infarction | 2 | MONDO:0004781 | EFO:0008583 |
| hepatitis C virus infection | 1 | MONDO:0005231 | EFO:0003047 |
| type 2 diabetes mellitus | 1 | MONDO:0005148 | MONDO:0005148 |
| neoplasm | 1 | MONDO:0005070 | MONDO:0004992 |
| bacterial vaginosis | 0 | MONDO:0005316 | EFO:0003932 |
4 further indication records had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 30.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 13 |
| PHASE2 | 6 |
| PHASE3 | 4 |
| PHASE1 | 3 |
| PHASE4 | 2 |
| PHASE2/PHASE3 | 1 |
| PHASE1/PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01594021 | PHASE4 | TERMINATED | Efficacy of Preemptive Volume Loading to Prevent Arterial Hypotension During Induction of General Anesthesia |
| NCT02631356 | PHASE4 | UNKNOWN | The Effect of Succinylated Gelatin on the Blood Viscosity and Oxygen Delivery |
| NCT00650143 | PHASE2/PHASE3 | COMPLETED | Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction |
| NCT01515397 | PHASE3 | COMPLETED | Comparison of Two Gelatine Solutions |
| NCT01527357 | PHASE3 | COMPLETED | A Study of Fibrocaps™ in Surgical Bleeding |
| NCT02644200 | PHASE3 | COMPLETED | Gelatin Tannate as Treatment for Acute Childhood Gastroenteritis |
| NCT02808325 | PHASE3 | COMPLETED | Study on the Efficacy and Safety of Gelaspan |
| NCT01256190 | PHASE2 | COMPLETED | A Study of Fibrocaps in Liver Surgery in the Netherlands |
| NCT02234466 | PHASE2 | UNKNOWN | Preoperative Oral Dexamethasone to Improve Recovery After Surgery |
| NCT02483962 | PHASE2 | COMPLETED | Venavine Intensive® in the Treatment of Symptoms Associated With Chronic Venous Insufficiency |
| NCT02498327 | PHASE2 | COMPLETED | The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous Insufficiency |
| NCT02541734 | PHASE1/PHASE2 | COMPLETED | Effect of Gelofusine on GLP1-receptor Imaging |
| NCT04057079 | PHASE2 | COMPLETED | Comparing Anugel With Gelatine Sponges for Pain Management After Hemoroidectomy |
| NCT04637308 | PHASE2 | COMPLETED | Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy |
| NCT02280759 | PHASE1 | COMPLETED | Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children. |
| NCT05235217 | PHASE1 | COMPLETED | Bioequivalence Study of Esomeprazole in Healthy Adult Subjects Under Fasting Condition |
| NCT05982353 | PHASE1 | COMPLETED | Gelatin Sponge VS PTFE Membrane for Socket Sealing After Immediate Implant Placement |
| NCT06435832 | Not specified | ACTIVE_NOT_RECRUITING | Evaluations of the Effects of Tranexamic Acid and Chlorhexidine Gel on Alveolar Osteitis Incidence |
| NCT00963196 | Not specified | WITHDRAWN | Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response |
| NCT01032343 | Not specified | COMPLETED | An Immunonutritional Approach to the Prevention of Skin Cancer |
| NCT01193764 | Not specified | TERMINATED | Study Assessing the Effect of Chocolate Consumption in Subjects With A History of Acne Vulgaris |
| NCT01293617 | Not specified | COMPLETED | Blackberry Intake and Biomarkers of Cancer Risk |
| NCT01526759 | Not specified | COMPLETED | Fiber Longer Term Study on Energy Intake |
| NCT02167178 | Not specified | COMPLETED | The Relationship Between Cardiac Output and Microvascular Visceral Blood Flow |
| NCT02495285 | Not specified | COMPLETED | Gelatines in Pediatric PatientS |
| NCT02566551 | Not specified | WITHDRAWN | Prospective Controlled Randomized Study of PAE vs TURP for BPH Treatment. |
| NCT03357432 | Not specified | COMPLETED | Gelatin, Collagen, Gummy and PINP |
| NCT03394833 | Not specified | COMPLETED | Hemodynamic Stability During Induction of Anaesthesia |
| NCT03944733 | Not specified | WITHDRAWN | Iron Status, Maternal Depressive Symptoms, and Mother-child Interactions |
| NCT06474052 | Not specified | COMPLETED | Volume Kinetics of Gelofusine 4% During Vascular Surgery |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.